骨细胞成熟障碍在肾性骨营养不良发病中的作用
该研究评估儿童透析患者与健康对照髂骨活检中骨细胞成熟与程序性细胞死亡标志物,发现CKD骨组织早期骨细胞增多、骨细胞凋亡减少,FGF23与早期骨细胞标志物E11/gp38共定位;CKD原代成骨细胞体外仍保留成熟与矿化缺陷。
要点
- CKD骨组织呈现早期骨细胞增多与骨细胞凋亡减少。
- FGF23共定位E11/gp38,提示其为早期骨细胞成熟标志。
- CKD原代成骨细胞体外保留成熟与矿化缺陷。
核心结论
- CKD与成骨细胞及骨细胞成熟的内在改变相关,FGF23标记骨细胞成熟相对早期阶段。
研究设计与样本
- 研究评估儿童透析患者与健康对照髂骨活检样本中骨细胞成熟与程序性细胞死亡标志物。
- 研究分析表达FGF23的骨细胞数量与骨矿化组织形态学参数的关系。
- 研究使用CKD患者与健康对照原代成骨细胞体外模型确认CKD导致骨细胞成熟的内在改变。
主要发现
- FGF23与早期骨细胞标志物E11/gp38共定位,提示FGF23是早期骨细胞成熟标志。
- CKD骨组织特征为早期骨细胞数量增加和骨细胞凋亡减少。
- 表达FGF23的骨细胞数量在骨骼矿化指标保留的患者中最高,且其周围基质包已进入二次矿化。
- CKD患者原代成骨细胞体外保留成熟与矿化特征受损。
- 添加FGF23不影响原代成骨细胞矿化。
临床怎么用
- 肾性骨营养不良与FGF23过多的改善需进一步研究CKD介导的成骨细胞与骨细胞成熟失败的发病机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pediatric renal osteodystrophy is characterized by skeletal mineralization defects, but the role of osteoblast and osteocyte maturation in the pathogenesis of these defects is unknown. We evaluated markers of osteocyte maturation and programmed cell death in iliac crest biopsy samples from pediatric dialysis patients and healthy controls. We evaluated the relationship between numbers of fibroblast growth factor 23 (FGF23)-expressing osteocytes and histomorphometric parameters of skeletal mineralization. We confirmed that chronic kidney disease (CKD) causes intrinsic changes in bone cell maturation using an in vitro model of primary osteoblasts from patients with CKD and healthy controls. FGF23 co-localized with the early osteocyte marker E11/gp38, suggesting that FGF23 is a marker of early osteocyte maturation. Increased numbers of early osteocytes and decreased osteocyte apoptosis characterized CKD bone. Numbers of FGF23-expressing osteocytes were highest in patients with preserved skeletal mineralization indices, and packets of matrix surrounding FGF23-expressing osteocytes appeared to have entered secondary mineralization. Primary osteoblasts from patients with CKD retained impaired maturation and mineralization characteristics in vitro. Addition of FGF23 did not affect primary osteoblast mineralization. Thus, CKD is associated with intrinsic changes in osteoblast and osteocyte maturation, and FGF23 appears to mark a relatively early stage in osteocyte maturation. Improved control of renal osteodystrophy and FGF23 excess will require further investigation into the pathogenesis of CKD-mediated osteoblast and osteocyte maturation failure.
引用
- Pereira RC, Salusky IB, Roschger P, et al. Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy. Kidney Int. 2018. PMID: 30348285. doi:10.1016/j.kint.2018.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。